Rosetta Genomics Ltd. (ROSG) Receives Full Settlement Payment From Sanra Laboratories
5/10/2013 10:00:56 AM
More...
|
Rosetta Genomics Ltd. (ROSG) microRNA-based Diagnostic Assays to be Showcased in an Industry Expert Theater Presentation at ASCO's 2013 Annual Meeting
5/7/2013 7:37:14 AM
More...
|
Rosetta Genomics Ltd. (ROSG) Reaches Settlement Agreement With Sanra Laboratories in Connection With Previous Sale of Parkway Clinical Laboratories
4/18/2013 10:31:44 AM
More...
|
Rosetta Genomics Ltd. (ROSG) Announces Poster Presentations at American Association for Cancer Research Annual Meeting 2013
4/3/2013 11:37:03 AM
More...
|
Rosetta Genomics Ltd. (ROSG) Announces Acceptance for Publication of Kidney Cancer microRNA Diagnostic Manuscript by Molecular Oncology
4/1/2013 9:48:37 AM
More...
|
Rosetta Genomics Ltd. (ROSG) to Host Business Update Conference Call on April 10, 2013
3/26/2013 9:07:20 AM
More...
|
Rosetta Genomics Ltd. (ROSG) Receives 25th U.S. Patent Allowance
3/18/2013 10:23:12 AM
More...
|
Rosetta Genomics Ltd. (ROSG) to Present at the 25th Annual Roth Conference
3/12/2013 7:36:24 AM
More...
|
Rosetta Genomics Ltd. (ROSG) Receives Two Key U.S. Patent Allowances
2/14/2013 9:41:13 AM
More...
|
Rosetta Genomics Ltd. (ROSG) Release: Study Validating Ability of microRNAs to Predict Progression of Bladder Cancer Published in British Journal of Urology International
2/7/2013 10:04:03 AM
More...
|
|